STRATA Skin Sciences (SSKN) Share-based Compensation Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.39% |
| Sep 30, 2025 | -12.06% |
| Jun 30, 2025 | -20.77% |
| Mar 31, 2025 | -21.40% |
| Dec 31, 2024 | -16.59% |
| Sep 30, 2024 | -36.76% |
| Jun 30, 2024 | -11.66% |
| Mar 31, 2024 | -19.09% |
| Dec 31, 2023 | -2.85% |
| Sep 30, 2023 | -1.69% |
| Jun 30, 2023 | 13.85% |
| Mar 31, 2023 | 76.45% |
| Dec 31, 2022 | 30.74% |
| Sep 30, 2022 | 48.50% |
| Jun 30, 2022 | 84.75% |
| Mar 31, 2022 | 47.90% |
| Dec 31, 2021 | 17.90% |
| Sep 30, 2021 | 22.50% |
| Jun 30, 2021 | 38.02% |
| Mar 31, 2021 | 31.24% |
| Dec 31, 2020 | 5.75% |
| Sep 30, 2020 | -16.74% |
| Jun 30, 2020 | 10.76% |
| Mar 31, 2020 | 13.33% |
| Dec 31, 2019 | 62.05% |
| Sep 30, 2019 | 17.45% |
| Jun 30, 2019 | 47.10% |
| Mar 31, 2019 | 14.49% |
| Dec 31, 2018 | 49.82% |
| Sep 30, 2018 | 18.12% |
| Jun 30, 2018 | -24.48% |
| Mar 31, 2018 | -41.12% |
| Dec 31, 2017 | -33.40% |
| Sep 30, 2017 | -28.27% |
| Jun 30, 2017 | -45.25% |
| Mar 31, 2017 | -31.61% |
| Dec 31, 2016 | -25.06% |
| Sep 30, 2016 | -44.37% |
| Jun 30, 2016 | -27.10% |
| Mar 31, 2016 | -0.08% |
| Dec 31, 2015 | 10.44% |
| Sep 30, 2015 | 38.67% |